Stanford Pain Relief Innovations Lab Guest Speaker Series: The Role of Acute Care Prescribing in the Opioid Epidemic (RECORDING)

Friday, July 7, 2023, 12:00 AM - Monday, July 6, 2026, 11:59 PM, On Demand

The Stanford Pain Relief Innovations lab, hosted by Dr. Beth Darnall, PhD, presents a virtual, monthly guest speaker series, inviting visiting professors in Pain Medicine, Pain Management and Pain Science. This topic is "The Role of Acute Care Prescribing in the Opioid Epidemic" presented by Chad M. Brummett, MD. During this lecture, Dr. Brummett discussed how increased opioid prescribing after surgery does not improve pain or satisfaction; it is associated with increased new chronic use, morbidity, and cost of care. Dr. Brummett also discussed outcomes from decreased opioid prescribing and pathways to reducing opioid-related morbidity and mortality.

  Release Date: July 7, 2023
  Expiration Date: July 6, 2026
  Estimated Time to Complete: 1.0 hour
  Registration Fee: FREE
 *Originally recorded 03/14/2023

For Pharmacists to Claim ACPE Credit:

If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Log in to Stanford's CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

View more DEA MATE resources and training accredited by Stanford CME at https://med.stanford.edu/cme/dea.html

AMA PRA Category 1 Credits™ (1.00 hours), AAPA Category 1 CME credits (1.00 hours), ACPE Contact Hours (1.00 hours), ANCC Contact Hours (1.00 hours), APA Continuing Education credits (1.00 hours), ASWB Continuing Education (ACE) credits (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Describe the risks and negative associated outcomes of opioid prescribing after surgery.
2. Implement strategies to reduce opioid-related morbidity and mortality by utilizing alternatives to opiates.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 1.0 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. 

UAN#: JA0000751-0000-23-011-H08-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Material for a maximum of 1.0 ANCC contact hours.  

ASWB Approved Continuing Education Credit (ACE)
As a Jointly Accredited Organization, Stanford Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this activity receive 1.0 continuing education credits.

American Academy of Physician Assistants (AAPA) - Enduring Material
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This Enduring Material is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until July 6, 2026. PAs should only claim credit commensurate with the extent of their participation.  

American Psychological Association (APA) 
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References:

Aalberg, J. J., Kimball, M. D., McIntire, T. R., & McCullen, G. M. (2022). Long-Term 
Outcomes of Persistent Post-Operative Opioid Use: A Retrospective Cohort Study. Annals of surgery, 10.1097/SLA.0000000000005372. Advance online publication. https://doi.org/10.1097/SLA.0000000000005372

Babu, K. M., Brent, J., & Juurlink, D. N. (2019). Prevention of Opioid Overdose. The New 
England journal of medicine, 380(23), 2246–2255. https://doi.org/10.1056/NEJMra1807054

Bateman, B. T., Cole, N. M., Maeda, A., Burns, S. M., Houle, T. T., Huybrechts, K. F., Clancy, 
C. R., Hopp, S. B., Ecker, J. L., Ende, H., Grewe, K., Raposo Corradini, B., Schoenfeld, R. E., Sankar, K., Day, L. J., Harris, L., Booth, J. L., Flood, P., Bauer, M. E., Tsen, L. C., … Leffert, L. R. (2017). Patterns of Opioid Prescription and Use After Cesarean Delivery. Obstetrics and gynecology, 130(1), 29–35. https://doi.org/10.1097/AOG.0000000000002093

Brescia, A. A., Waljee, J. F., Hu, H. M., Englesbe, M. J., Brummett, C. M., Lagisetty, P. A., & 
Lagisetty, K. H. (2019). Impact of Prescribing on New Persistent Opioid Use After Cardiothoracic Surgery. The Annals of thoracic surgery, 108(4), 1107–1113. https://doi.org/10.1016/j.athoracsur.2019.06.019

Brown, C. S., Vu, J. V., Howard, R. A., Gunaseelan, V., Brummett, C. M., Waljee, J., & 
Englesbe, M. (2021). Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system. BMJ quality & safety, 30(3), 251–259. https://doi.org/10.1136/bmjqs-2020-011295

Brummett, C. M., Evans-Shields, J., England, C., Kong, A. M., Lew, C. R., Henriques, C., 
Zimmerman, N. M., & Sun, E. C. (2021). Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients. Journal of managed care & specialty pharmacy, 27(6), 760–771. https://doi.org/10.18553/jmcp.2021.20507

Brummett, C. M., Steiger, R., Englesbe, M., Khalsa, C., DeBlanc, J. J., Denton, L. R., & Waljee, 
J. (2019). Effect of an Activated Charcoal Bag on Disposal of Unused Opioids After an Outpatient Surgical Procedure: A Randomized Clinical Trial. JAMA surgery, 154(6), 558–561. https://doi.org/10.1001/jamasurg.2019.0155

Brummett, C. M., Waljee, J. F., Goesling, J., Moser, S., Lin, P., Englesbe, M. J., Bohnert, A. S. 
B., Kheterpal, S., & Nallamothu, B. K. (2017). New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA surgery, 152(6), e170504. https://doi.org/10.1001/jamasurg.2017.0504

Delaney, L. D., Gunaseelan, V., Rieck, H., Dupree, J. M., 4th, Hallstrom, B. R., & Waljee, J. F. 
(2020). High-Risk Prescribing Increases Rates of New Persistent Opioid Use in Total Hip Arthroplasty Patients. The Journal of arthroplasty, 35(9), 2472–2479.e2. https://doi.org/10.1016/j.arth.2020.04.019

Harbaugh, C. M., Nalliah, R. P., Hu, H. M., Englesbe, M. J., Waljee, J. F., & Brummett, C. M. 
(2018). Persistent Opioid Use After Wisdom Tooth Extraction. JAMA, 320(5), 504–506. https://doi.org/10.1001/jama.2018.9023

Hill, M. V., McMahon, M. L., Stucke, R. S., & Barth, R. J., Jr (2017). Wide Variation and 
Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Annals of surgery, 265(4), 709–714. https://doi.org/10.1097/SLA.0000000000001993

Howard, R., Waljee, J., Brummett, C., Englesbe, M., & Lee, J. (2018). Reduction in Opioid 
Prescribing Through Evidence-Based Prescribing Guidelines. JAMA surgery, 153(3), 285–287. https://doi.org/10.1001/jamasurg.2017.4436

Larach, D. B., Waljee, J. F., Hu, H. M., Lee, J. S., Nalliah, R., Englesbe, M. J., & Brummett, C. 
M. (2020). Patterns of Initial Opioid Prescribing to Opioid-Naive Patients. Annals of surgery, 271(2), 290–295. https://doi.org/10.1097/SLA.0000000000002969

Lee, J. S., Hu, H. M., Brummett, C. M., Syrjamaki, J. D., Dupree, J. M., Englesbe, M. J., & 
Waljee, J. F. (2017). Postoperative Opioid Prescribing and the Pain Scores on Hospital Consumer Assessment of Healthcare Providers and Systems Survey. JAMA, 317(19), 2013–2015. https://doi.org/10.1001/jama.2017.2827

Mariano, E. R., Dickerson, D. M., Szokol, J. W., Harned, M., Mueller, J. T., Philip, B. K., 
Baratta, J. L., Gulur, P., Robles, J., Schroeder, K. M., Wyatt, K. E. K., Schwalb, J. M., Schwenk, E. S., Wardhan, R., Kim, T. S., Higdon, K. K., Krishnan, D. G., Shilling, A. M., Schwartz, G., Wiechmann, L., … Buvanendran, A. (2022). A multisociety organizational consensus process to define guiding principles for acute perioperative pain management. Regional anesthesia and pain medicine, 47(2), 118–127. https://doi.org/10.1136/rapm-2021-103083

Santosa, K. B., Wang, C. S., Hu, H. M., Mullen, C. R., Brummett, C. M., Englesbe, M. J., 
Bicket, M. C., Myers, P. L., & Waljee, J. F. (2022). Opioid Coprescribing with Sedatives after Implant-Based Breast Reconstruction. Plastic and reconstructive surgery, 150(6), 1224e–1235e. https://doi.org/10.1097/PRS.0000000000009726

Sekhri, S., Arora, N. S., Cottrell, H., Baerg, T., Duncan, A., Hu, H. M., Englesbe, M. J., 
Brummett, C., & Waljee, J. F. (2018). Probability of Opioid Prescription Refilling After Surgery: Does Initial Prescription Dose Matter?. Annals of surgery, 268(2), 271–276. https://doi.org/10.1097/SLA.0000000000002308

University of Texas at Austin, The. (2022). Acute to Chronic Pain Signatures, Homepage. Acute 
to Chronic Pain Signatures, Texas Advanced Computing Center. https://a2cps.org/

Verret, M., Lauzier, F., Zarychanski, R., Perron, C., Savard, X., Pinard, A. M., Leblanc, G., 
Cossi, M. J., Neveu, X., Turgeon, A. F., & Canadian Perioperative Anesthesia Clinical Trials (PACT) Group (2020). Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis. Anesthesiology, 133(2), 265–279. https://doi.org/10.1097/ALN.0000000000003428

Vu, J. V., Howard, R. A., Gunaseelan, V., Brummett, C. M., Waljee, J. F., & Englesbe, M. J. 
(2019). Statewide Implementation of Postoperative Opioid Prescribing Guidelines. The New England journal of medicine, 381(7), 680–682. https://doi.org/10.1056/NEJMc1905045

Wilton, J., Abdia, Y., Chong, M., Karim, M. E., Wong, S., MacInnes, A., Balshaw, R., Zhao, B., 
Gomes, T., Yu, A., Alvarez, M., Dart, R. C., Krajden, M., Buxton, J. A., Janjua, N. Z., & Purssell, R. (2021). Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study. BMJ (Clinical research ed.), 375, e066965. https://doi.org/10.1136/bmj-2021-066965

For activity related questions, please contact

     Name: Holly Meyer
     Title: CME Compliance Coordinator
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.